Brief: Aft Pharmaceuticals Says Co Has Reached Agreement With Massey Ventures And Gillies Mcindoe Research Institute
01/09/2022 02:45
Sept 1 (Reuters) - AFT Pharmaceuticals AFT.NZ :
* CO HAS REACHED AGREEMENT WITH MASSEY VENTURES AND GILLIES
MCINDOE RESEARCH INSTITUTE
* DEAL TO LICENSE INTELLECTUAL PROPERTY TO ALLOW DEVELOPMENT
OF
TOPICAL TREATMENT FOR STRAWBERRY BIRTHMARKS IN CHILDREN
Source text for Eikon: ID:nASX7Mv9ph
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV